Sort
30,917 grants matching “tumor microenvironment”
METEOR-BioLogical Specimen Translation (METEOR-BLST)
$386,855Michael Benjamin Major · Washington University · U54 · FY2024 · CA
Targeting Syk to enhance anti-tumor immune responses in neuroblastoma
$386,825Shweta Joshi · University Of California, San Diego · R01 · FY2024 · NS
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$386,817Bo Li · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$386,817Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Research Project Cervical Cancer
$386,806Julie Kristina Schwarz · Washington University · U54 · FY2023 · CA
Endothelial plasticity in glioma vascularization and therapy resistance
$386,788Yi Fan · University Of Pennsylvania · R01 · FY2024 · NS
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis
$386,717Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
New Multi-Drug Resistance Mechanism in Multiple Myeloma
$386,661Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2022 · CA
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
$386,650Raymond Nelson Dubois · Medical University Of South Carolina · R01 · FY2016 · CA
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
$386,650Raymond Nelson Dubois · Medical University Of South Carolina · R01 · FY2017 · CA
New Multi-Drug Resistance Mechanism in Multiple Myeloma
$386,611Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2024 · CA
A novel preclinical model of spontaneous metastasis
$386,586Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Development of CA-IL-12 for Triple Negative Breast Cancer
$386,586Richard L. Klemke · Cytonus Therapeutics, Inc. · R41 · FY2020 · CA
N-cadherin in Extraskeletal Osteolineage Cells Modulates Tumor Growth
$386,582Roberto Civitelli · Washington University · R01 · FY2022 · CA
Projecdt 3 - Modulation of bone environment to enhance response of bone cancers
$386,509John F Dipersio · Washington University · U54 · FY2015 · CA
Proj 2 - Exploiting Therapeutic Vulnerabilities
$386,498William A Weiss · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA
Fibrinogen-coated albumin nanospheres for mitigation of irradiation-induced wound healing impairment in breast cancer patients.
$386,470Richard Yen · Fibroplate, Inc. · R43 · FY2024 · CA
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis
$386,459Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
CANCAN - COLDSPRING
$386,428Tobias Janowitz · Cold Spring Harbor Laboratory · OT2 · FY2023 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$386,374Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2022 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$386,374Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2021 · CA
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
$386,374Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2020 · CA
Distinct Pathways of VPF/VEGF Receptors
$386,365Debabrata Mukhopadhyay · Mayo Clinic Rochester · R01 · FY2014 · HL
Imaging the stem cell niche in regeneration and cancer
$386,354Tannishtha Reya · University Of California, San Diego · R01 · FY2011 · HL
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
$386,339Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2013 · CA